Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilse R Kelters

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Heart Journal|July 15, 2025
Circadian rhythms in cardiovascular diseaseIlse R Kelters, Yvonne Koop, Martin E Young, et al.
Stem Cell Research|July 25, 2024
Generation of human induced pluripotent stem cell (hiPSC) lines derived from three patients carrying the pathogenic CRYAB (A527G) mutation and one non-carrier family memberIlse R Kelters, Devin Verbueken, Tess Beekink, et al.
Cardiovascular Research|October 6, 2025
Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicityIlse R Kelters, Markella I Printezi, Annabelle Ballesta, et al.
British Journal of Pharmacology|May 29, 2025
Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept studyJort S A van der Geest, Ilse R Kelters, Bauke Arends, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Heart Journal|July 15, 2025
Circadian rhythms in cardiovascular diseaseIlse R Kelters, Yvonne Koop, Martin E Young, et al.
Stem Cell Research|July 25, 2024
Generation of human induced pluripotent stem cell (hiPSC) lines derived from three patients carrying the pathogenic CRYAB (A527G) mutation and one non-carrier family memberIlse R Kelters, Devin Verbueken, Tess Beekink, et al.
Cardiovascular Research|October 6, 2025
Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicityIlse R Kelters, Markella I Printezi, Annabelle Ballesta, et al.
British Journal of Pharmacology|May 29, 2025
Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept studyJort S A van der Geest, Ilse R Kelters, Bauke Arends, et al.
Pageof 1